WallStSmart
MASS

908 Devices Inc

NASDAQ: MASS · HEALTHCARE · MEDICAL DEVICES

$7.30
-2.15% today

Updated 2026-06-03

Market cap
$299.86M
P/E ratio
P/S ratio
5.19x
EPS (TTM)
$-0.97
Dividend yield
52W range
$5 – $9
Volume
0.3M

908 Devices Inc (MASS) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20182019202020212022202320242025
Total assets$27.75M$37.66M$178.83M$260.91M$242.59M$202.98M$159.48M$190.07M
Cash & equivalents$7.07M$17.91M$159.23M$224.07M$188.42M$121.04M$44.03M$112.97M
Current assets$17.20M$28.58M$170.97M$252.89M$215.63M$173.79M$103.06M$144.56M
Total liabilities$77.92M$100.83M$39.79M$46.30M$51.99M$37.49M$44.88M$46.37M
Current liabilities$4.76M$6.05M$10.83M$14.84M$19.23M$22.55M$25.15M$34.06M
Long-term debt$9.65M$14.77M$14.33M$15.00M$15.00M
Shareholder equity$-50.18M$-63.17M$139.04M$214.60M$190.60M$165.49M$114.59M$143.70M
Retained earnings$-52.28M$-65.65M$-78.47M$-100.64M$-134.20M$-170.60M$-242.81M$-223.32M
Accounts receivable$6.34M$5.08M$6.83M$16.57M$10.03M$8.99M$12.63M$11.33M
Inventory$3.52M$5.24M$4.57M$7.92M$12.51M$14.94M$16.17M$12.99M
Goodwill$0.00$10.05M$10.37M$0.00

Frequently asked questions

What is 908 Devices Inc's revenue?

908 Devices Inc's trailing twelve-month revenue is $57.80M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is MASS?

In its most recent fiscal year, MASS ran a gross margin of 47.68%, an operating margin of -43.03%, and a net margin of -65.20%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does MASS generate?

MASS produced $-24.64M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is MASS's balance sheet healthy?

MASS holds $112.97M in cash and equivalents against — in long-term debt, on $143.70M of shareholder equity. That debt is best read against the cash flow the business throws off each year.